For instance, in April 2025, Pfizer, a US-based pharmaceutical company specializing in metabolic and cardiometabolic drug development, provided an update on its oral GLP-1 receptor agonist candidate, danuglipron, following the completion of once-daily formulation studies intended to improve dosing convenience for patients
Lets take a closer look at what L-Carnitine actually does in the body and how it supports weight management What is L-Carnitine
Pediatrics , 151 (2), e2022060640
Currently, there is no FDA-approved indication for GLP-1 receptor agonists in the treatment of Crohn's disease or any form of IBD
With a team of dedicated professionals and personalized care plans, we are committed to guiding you towards a healthier and happier lifestyle